Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103527 · ClinicalTrials.gov registry record · NA
Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain
A NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Kenneth B Chapman.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05103527: Active NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Kenneth B Chapman.
NCT05103527 is a NA study of Knee Osteoarthritis and Knee Pain Chronic that is active but no longer recruiting, run by Kenneth B Chapman. The registered enrollment target is 30 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05103527, a NA study of Knee Osteoarthritis and Knee Pain Chronic, is active but no longer recruiting, sponsored by Kenneth B Chapman.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Dorsal root ganglion stimulation (DRG-S) may be able to treat mechanical pain caused by tissue injury or damage such as trauma or arthritis in addition to pain caused by nerve dysfunction or injury. The purpose of this study is to determine if dorsal root ganglion stimulation (DRG-S) can effectively treat arthritic pain of the knee.
Primary Outcome
Percent of DRG-S implanted patients that successfully respond to stimulation therapy as defined by \>=50% reduction in reported pain score from baseline
Conditions Studied
Interventions
- DEVICE Dorsal Root Ganglion Stimulation
Study Locations (1)
New York
- The Spine and Pain Institute of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT05103527 still lists
NCT05103527 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower).
The record links to 4 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Dorsal Root Ganglion Stimulation is the first listed.
NCT05103527 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05103527 about?
NCT05103527 is a clinical study titled "Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain". Dorsal root ganglion stimulation (DRG-S) may be able to treat mechanical pain caused by tissue injury or damage such as trauma or arthritis in addition to pain caused by nerve dysfunction or injury. The purpose of this study is to determine if dorsal root ganglion stimulation (DRG-S) can effectively...
What is the current status of trial NCT05103527?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-01-01. Estimated completion is 2026-05.
What conditions does trial NCT05103527 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis, Knee Arthropathy.
What interventions are being tested in trial NCT05103527?
The interventions under investigation include: Dorsal Root Ganglion Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05103527?
This trial is sponsored by Kenneth B Chapman, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05103527 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05103527's enrollment target sits among peer trials
30 80th of 101 higher than 15 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Knee Biofeedback Rehabilitation Through Game Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI